Ahmed Nasreldein: Stay Current on Key Updates in Ischemic and Hemorrhagic Stroke
Ahmed Nasreldein, Professor of Neurology at Assiut University, reposted from MENA Vascular and Interventional Neurology Society on LinkedIn:
”Interested in the latest updates in stroke?
Join us for an upcoming webinar highlighting the newest studies and key updates in both ischemic and hemorrhagic stroke.
Don’t miss this opportunity to stay current with emerging evidence and clinical insights.”
Quoting MENA Vascular and Interventional Neurology Society (MENA-VINS)‘s post:
”MENA-VINS (MENA Vascular and Interventional Neurology Society) is pleased to announce the initiation of the online thread of scientific webinars under the title ‘Global Perspectives in Stroke Management: An Evening with Prof. Magdy Selim‘ moderated by Prof. Ahmed Nasreldein and Prof. Mostafa Melek
Join us for an exclusive webinar exploring the cutting-edge advancements in stroke and intracerebral hemorrhage treatments.
We will dive into the most impactful recent research and discuss how these findings are reshaping clinical practice in this fast-paced field.
We are honored to host Prof. Magdy Selim, Professor and Chief of the Stroke Division at Harvard, for this session.
This is a premier opportunity for neurologists, ER specialists, and intensivist physicians to engage with evidence-based updates and global best practices.
Celebrate a productive Ramadan evening with us through high-level scientific dialogue.
Date: Friday, March 6
Time: 10:00 PM Cairo local time
8:00 PM GMT”
Stay updated with Hemostasis Today.
-
Feb 26, 2026, 15:15Shannon Farmer: What Happens to Vital Signs Pre and Post 1-Unit and 2-Unit RBC Transfusion?
-
Feb 26, 2026, 15:08Emmanuel J Favaloro: When Is A ‘Subtype’ of VWD Not Really VWD?
-
Feb 26, 2026, 15:03Gregory Piazza: Importance of Recognizing PE As A Wide Spectrum of Presentations and Greater Range of Adverse Outcomes
-
Feb 26, 2026, 14:57Abdulla A. Damluji: Sex As An Effect Measure Modifier Between Frailty and Outcomes in AMI Patients
-
Feb 26, 2026, 14:48Ney Carter Borges: The APERITIF Trial Clarifies Rivaroxaban’s Role in LVT
-
Feb 26, 2026, 14:44Wolfgang Miesbach: Synovitis and Haemophilia in Focus at GTH2026
-
Feb 26, 2026, 14:40Al-Ola Abdallah: How Much Does It Cost to Publish in Hematology and Oncology Journals
-
Feb 26, 2026, 14:38Chris Hillis: Newly Updated Choosing Wisely Canada – Hematology Recommendations
-
Feb 26, 2026, 14:37Inflammatory-Coagulation Cascade Interactions in Trauma-Induced Coagulopathy – JTH